What is Subcutaneous immune globulin?

Category: Prescription Drugs

Most popular types: Hizentra CUVITRU HyQvia Show all

false

Subcutaneous immune globulin is used in the treatment of primary humoral immunodeficiency.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Common variable immune deficiency 28 25
Hypogammaglobulinemia 12 16
Chronic inflammatory demyelinating polyneuropathy 4 7
IgG deficiency 3 2
Specific antibody deficiency 3 1
Peripheral neuropathy 1 2

Show all 7 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 2
Moderate 10
Mild 29
None 9

Commonly reported side effects and conditions associated with Subcutaneous immune globulin

Side effect Patients Percentage
Injection site pain 5
Injection site swelling 5
Fatigue 4
Headaches 3
Chills 2
Diarrhea 2

Show all 35 reported side effects

Dosages

Based on patients currently taking Subcutaneous immune globulin

Dosage Patients Percentage
200 mg weekly 4
6 mg every other week 1
36 g monthly 1
10 g weekly 1
10 mg weekly 1
40 mg every other week 1
70 mg every other week 1
100 mg every other week 1
50 mL weekly 1
60 mL weekly 1

See all 13 dosages

Why patients stopped taking Subcutaneous immune globulin

Multiple reasons could be selected

Reason Patients Percentage
Side effects too severe 3
Did not seem to work 2
Other 2
Change in health plan coverage 1
Expense 1
See all 4 patients who've stopped taking Subcutaneous immune globulin

Duration

Currently taking Subcutaneous immune globulin

Duration Patients Percentage
Less than 1 month 1
1 - 6 months 2
6 months - 1 year 2
1 - 2 years 2
2 - 5 years 5
5 - 10 years 2
10 years or more 3

Stopped taking Subcutaneous immune globulin

Duration Patients Percentage
Less than 1 month 1
1 - 6 months 1
2 - 5 years 2
Adherence
Adherence Evaluations Percentage
Always 43
Usually 6
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations Percentage
Very hard to take 7
Somewhat hard to take 15
A little hard to take 11
Not at all hard to take 17
Cost per month
Cost per month Evaluations Percentage
$200+ 11
$100-199 0
$50-99 3
$25-49 0
< $25 13
Not specified 23

What people switch to and from

Patients started taking Subcutaneous immune globulin after stopping:

Treatment Patients Percentage
Intravenous Immunoglobulin (IVIG) (Gammaglobulin (IVIg)) 14
Subcutaneous immune globulin (Hizentra) 2

Patients stopped taking Subcutaneous immune globulin and switched to:

Treatment Patients Percentage
Intravenous Immunoglobulin (IVIG) (Gammaglobulin (IVIg)) 2
Subcutaneous immune globulin (Hizentra) 2
Last updated:
There are no evaluations for Subcutaneous immune globulin.